Stockscreener 앱 받기
7.97
3.39%
-0.28
전일 마감가:
$8.25
열려 있는:
$8.18
하루 거래량:
305.64K
Relative Volume:
0.79
시가총액:
$442.94M
수익:
순이익/손실:
$-161.15M
주가수익비율:
-2.1454
EPS:
-3.7149
순현금흐름:
$-138.61M
1주 성능:
-0.38%
1개월 성능:
-23.80%
6개월 성능:
-73.22%
1년 성능:
+0.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$7.84
$8.58
52주 변동 폭
$7.46
$40.43
Maplight Therapeutics Inc Stock (MPLT) Company Profile
명칭
Maplight Therapeutics Inc
전화
650-839-4360
주소
800 CHESAPEAKE DRIVE, REDWOOD CITY
Compare MPLT vs VRTX, REGN, MRNA, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MPLT
Maplight Therapeutics Inc
|
7.97 | 442.94M | 0 | -161.15M | -138.61M | -3.7149 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Maplight Therapeutics Inc Stock (MPLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-06 | 개시 | Guggenheim | Neutral |
| 2026-08-10 | 다운그레이드 | UBS | Buy → Neutral |
| 2026-07-28 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2026-07-21 | 개시 | BMO Capital Markets | Outperform |
| 2026-06-25 | 개시 | Raymond James | Strong Buy |
| 2026-05-27 | 개시 | UBS | Buy |
| 2026-05-21 | 개시 | Craig Hallum | Buy |
| 2026-05-04 | 개시 | H.C. Wainwright | Buy |
| 2026-04-08 | 개시 | Needham | Buy |
| 2026-04-07 | 개시 | TD Cowen | Buy |
| 2026-03-19 | 개시 | Canaccord Genuity | Buy |
| 2025-11-21 | 개시 | Jefferies | Buy |
| 2025-11-21 | 개시 | Leerink Partners | Outperform |
| 2025-11-21 | 개시 | Morgan Stanley | Overweight |
| 2025-11-21 | 개시 | Stifel | Buy |
모두보기
Maplight Therapeutics Inc 주식(MPLT)의 최신 뉴스
MapLight Therapeutics’ Kreitzer sells $96,024 in common stock By Investing.com - Investing.com South Africa
MapLight Therapeutics CMO Erin Foff sells $124,068 in stock By Investing.com - Investing.com South Africa
Form 4 MapLight Therapeutics Inc: James Woodruff Lillie (Chief Scientific Officer) For: 15 October - Investing.com Nigeria
MapLight Therapeutics CMO Erin Foff sells $124,068 in stock - Investing.com
MapLight Therapeutics chief scientific officer sells $93,025 in shares - Investing.com
MapLight Therapeutics general counsel reports $72,881 stock sale - Investing.com
MapLight Therapeutics CAO sells $82,149 in shares - Investing.com
MapLight Therapeutics’ Kreitzer sells $96,024 in common stock - Investing.com
MapLight Therapeutics CAO sells $82,149 in shares By Investing.com - Investing.com UK
MapLight Therapeutics chief scientific officer sells $93,025 in shares By Investing.com - Investing.com UK
Form 4 MapLight Therapeutics Inc: Anatol Kreitzer (Chief Discovery Officer) For: 15 October - Investing.com Nigeria
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com Nigeria
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com India
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com UK
MapLight Therapeutics Officer Christopher Kroeger Files to Sell 73,691 Shares to Cover RSU Tax Withholding - Kalkine Media
MapLight Therapeutics Officer Lillie James Woodruff to Sell 11,513 Shares for RSU Tax Withholding - Kalkine Media
MapLight Therapeutics Director Robert Malenka Announces Sale of 14,809 RSU Shares via Rule 144 - Kalkine Media
Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com - Investing.com Nigeria
Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com - Investing.com Australia
MapLight Therapeutics (MPLT) exec to sell shares under preset trading plan - stocktitan.net
MapLight Therapeutics, Inc. (MPLT) Stock Price Quote Today & Current Price Chart - Capital.com
MapLight Therapeutics to Participate in Upcoming Investor Conference - The Manila Times
BlackRock Inc. Takes $36.74 Million Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading Up 5.3%Here's What Happened - MarketBeat
Needham cuts MapLight Therapeutics price target on dilution concerns By Investing.com - Investing.com Canada
Needham cuts MapLight Therapeutics price target on dilution concerns By Investing.com - Investing.com India
Maplight Therapeutics (NASDAQ:MPLT) Price Target Lowered to $43.00 at Needham & Company LLC - MarketBeat
Freestone Grove Partners LP Makes New $6.05 Million Investment in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Nan Fung Group Holdings Ltd Makes New $34.81 Million Investment in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading Down 4.6%What's Next? - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading 7.8% HigherShould You Buy? - MarketBeat
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Segal Trials Reinforces Leadership in Acute Schizophrenia Research Following Participation in MapLight Therapeutics’ Phase 2 ZEPHYR Study - Business Wire
Blue Owl Capital Holdings LP Takes $26.16 Million Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
MPLT: MapLight Therapeutics, Inc.Financial Overview - Zacks Investment Research
MapLight Therapeutics (MPLT): Nan Fung group holds passive stake above 5% - Stock Titan
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Down 7%Should You Sell? - MarketBeat
MapLight Therapeutics (MPLT) grants CDO 24K options and 6K RSUs - stocktitan.net
MapLight (NASDAQ: MPLT) grants CEO 93,955 options and 23,145 RSUs - Stock Titan
MapLight Therapeutics (MPLT) grants CSO new options and RSUs - stocktitan.net
MapLight Therapeutics (MPLT) lifts GC stake with 31K options - stocktitan.net
MapLight (MPLT) Reported Results Review: The EPS Result Is Below Expectation in the Reported Period; Trading-Day Reaction: Shares Rise 5.11% in Latest TradingGuidance Downgrade Alert - Vinanet
Catalyst4 builds 49.9% MapLight (MPLT) stake in private share deal - Stock Titan
MapLight Therapeutics, Inc. (MPLT) - Zacks Investment Research
MapLight Therapeutics announces $150M private placement - TipRanks
Morgan Stanley Maintains MapLight Therapeutics(MPLT.US) With Hold Rating, Maintains Target Price $21 - Moomoo
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
LifeSci Capital Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Maintains Target Price $37 - Moomoo
BMO Capital Initiates MapLight Therapeutics(MPLT.US) With Buy Rating, Announces Target Price $20 - Moomoo
MapLight presses the pause button; ADC Therapeutics considers what to do with Zynlonta - Endpoints News
Maplight Therapeutics Inc (MPLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Maplight Therapeutics Inc 주식 (MPLT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Foff Erin Pennock | Chief Medical Officer |
Oct 15 '26 |
Sale |
8.08 |
15,355 |
124,068 |
296,906 |
| Kroeger Christopher A. | Chief Executive Officer |
Oct 15 '26 |
Sale |
8.08 |
73,691 |
595,423 |
1,195,909 |
| Lillie James Woodruff | Chief Scientific Officer |
Oct 15 '26 |
Sale |
8.08 |
11,513 |
93,025 |
198,597 |
| Lillie James Woodruff | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
11,513 |
89,917 |
0 |
| Kroeger Christopher A. | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
73,691 |
575,527 |
0 |
| GILLIS JONATHAN | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
10,167 |
79,404 |
0 |
| Hanson Kristopher | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
9,020 |
70,446 |
0 |
| Foff Erin Pennock | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
15,355 |
119,922 |
0 |
| GILLIS JONATHAN | CAO and Interim CFO |
Oct 15 '26 |
Sale |
8.08 |
10,167 |
82,149 |
142,315 |
| Anatol Kreitzer | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
12,500 |
97,625 |
0 |
3.09%
0.72%
자본화:
|
볼륨(24시간):